ProterixBio, Inc. will be attending Biotech Showcase™ 2017, to be held January 9-11th at the Hilton San Francisco Union Square. Biotech Showcase™ 2017 is one of the industry’s largest annual healthcare investor and partnering conferences, with more than 300 company presentations and 2,800+ attendees expected. Attendees include biopharmaceutical and life science company executives, investors in private and public companies, sector analysts, bankers and industry professionals. The conference is run concurrently with, but independently from, the JP Morgan Healthcare Conference in San Francisco, one of the largest and most influential international healthcare conferences.

Michael F. Miller, Ph.D., president and chief executive officer of ProterixBio, will speak at the conference. He will be highlighting ProterixBio’s innovative disease management solutions that integrate proprietary biomarker tests with digital health tools to transform the diagnosis, monitoring and management of chronic diseases, with an initial focus on pulmonary diseases such as COPD (chronic obstructive pulmonary disease).